Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
KO CocaCola	$68.84 -0.5%	$71.50	$60.62 ▼ $74.38	$296.31B	0.46	15.98 million shs	40.84 million shs
O Realty Income	$57.24 -0.6%	$56.74	$50.71 ▼ $64.88	$51.64B	0.76	5.22 million shs	16.93 million shs
PFE Pfizer	$23.97 +0.4%	$23.26	$20.92 ▼ $31.54	$136.28B	0.57	41.34 million shs	62.63 million shs

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
KO CocaCola	-0.44%	-2.96%	-4.17%	+0.39%	+9.92%
O Realty Income	-0.54%	-0.64%	+3.54%	+2.61%	+7.80%
PFE Pfizer	+0.39%	-2.22%	+3.94%	-8.53%	-12.56%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
KO CocaCola	4.677 of 5 stars	3.5	5.0	3.3	0.8	2.5	2.5	1.3
O Realty Income	3.4115 of 5 stars	2.2	2.0	2.5	1.7	3.4	1.7	0.6
PFE Pfizer	4.8774 of 5 stars	2.3	4.0	4.2	4.3	2.9	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
KO CocaCola	3.05	Buy	$76.00	10.39% Upside
O Realty Income	2.31	Hold	$61.15	6.83% Upside
PFE Pfizer	2.53	Moderate Buy	$29.17	21.69% Upside

Current Analyst Ratings Breakdown

Latest KO, O, and PFE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/9/2025	KO CocaCola	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$81.00
5/13/2025	O Realty Income	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$64.00 ➝ $62.00
5/12/2025	O Realty Income	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$57.00 ➝ $58.00
5/7/2025	O Realty Income	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$61.00 ➝ $61.00
5/6/2025	O Realty Income	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$65.50 ➝ $68.00
5/5/2025	O Realty Income	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$64.00 ➝ $61.00
4/30/2025	KO CocaCola	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$73.00 ➝ $76.00
4/30/2025	KO CocaCola	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$84.00 ➝ $86.00
4/30/2025	PFE Pfizer	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$24.00 ➝ $25.00
4/22/2025	O Realty Income	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
4/22/2025	O Realty Income	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$59.00 ➝ $58.00

(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
KO CocaCola	$47.06B	6.30	$3.14 per share	21.90	$6.12 per share	11.25
O Realty Income	$5.39B	9.59	$3.81 per share	15.01	$44.62 per share	1.28
PFE Pfizer	$63.63B	2.14	$4.37 per share	5.49	$15.62 per share	1.53

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
KO CocaCola	$10.63B	$2.50	27.54	21.58	3.61	23.00%	45.49%	12.18%	7/22/2025 (Estimated)
O Realty Income	$860.77M	$1.10	52.04	13.25	4.00	18.15%	2.51%	1.42%	8/4/2025 (Estimated)
PFE Pfizer	$8.03B	$1.38	17.37	7.91	0.87	12.62%	20.33%	8.53%	7/29/2025 (Estimated)

Latest KO, O, and PFE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/5/2025	Q1 2025	O Realty Income	$1.06	$1.06	N/A	$1.06	$1.28 billion	$1.31 billion
4/29/2025	Q1 2025	KO CocaCola	$0.71	$0.73	+$0.02	$0.77	$11.23 billion	$11.13 billion
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
KO CocaCola	$2.04	2.96%	N/A	81.60%	64 Years
O Realty Income	$3.22	5.63%	N/A	292.73%	1 Years
PFE Pfizer	$1.72	7.18%	N/A	124.64%	16 Years

Latest KO, O, and PFE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/10/2025	O Realty Income	jul 25	$0.2690	5.6%	7/1/2025	7/1/2025	7/15/2025
5/1/2025	KO CocaCola	quarterly	$0.51	2.86%	6/13/2025	6/13/2025	7/1/2025
5/12/2025	O Realty Income	jun 25	$0.2685	5.8%	6/2/2025	6/2/2025	6/13/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025
4/8/2025	O Realty Income	may 25	$0.2685	6%	5/1/2025	5/1/2025	5/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
KO CocaCola	1.57	1.10	0.89
O Realty Income	0.69	1.74	1.74
PFE Pfizer	0.64	1.26	0.96

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
KO CocaCola	70.26%
O Realty Income	70.81%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
KO CocaCola	0.97%
O Realty Income	0.10%
PFE Pfizer	0.06%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
KO CocaCola	69,700	4.30 billion	4.26 billion	Optionable
O Realty Income	400	903.08 million	902.18 million	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable

KO, O, and PFE Headlines

Recent News About These Companies

Center For Asset Management LLC Reduces Stake in Pfizer Inc. (NYSE:PFE)

June 21 at 7:21 AM | marketbeat.com

Woodmont Investment Counsel LLC Acquires 16,987 Shares of Pfizer Inc. (NYSE:PFE)

June 21 at 7:00 AM | marketbeat.com

Monte Financial Group LLC Purchases 43,740 Shares of Pfizer Inc. (NYSE:PFE)

June 21 at 6:50 AM | marketbeat.com

World Equity Group Inc. Sells 38,707 Shares of Pfizer Inc. (NYSE:PFE)

June 21 at 6:25 AM | marketbeat.com

PFG Investments LLC Grows Position in Pfizer Inc. (NYSE:PFE)

June 21 at 5:50 AM | marketbeat.com

Advocate Group LLC Increases Stock Position in Pfizer Inc. (NYSE:PFE)

June 21 at 5:50 AM | marketbeat.com

Advisor Resource Council Invests $1.55 Million in Pfizer Inc. (NYSE:PFE)

June 21 at 5:21 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Position Reduced by United Advisor Group LLC

June 21 at 4:39 AM | marketbeat.com

Pfizer (NYSE:PFE) Joins FIBRE Consortium To Advance Fibrosis Treatment Through Innovative Imaging

June 20 at 2:24 PM | finance.yahoo.com

Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?

June 20 at 11:06 AM | zacks.com

June 20 at 10:00 AM | zacks.com

Will Pfizer Slash Its >7% Yielding Dividend? I Wouldn't Rule It Out

June 20 at 9:06 AM | seekingalpha.com

Private Wealth Partners LLC Raises Holdings in Pfizer Inc. (NYSE:PFE)

June 20 at 7:36 AM | marketbeat.com

Cantor Fitzgerald Investment Advisors L.P. Sells 14,500 Shares of Pfizer Inc. (NYSE:PFE)

June 20 at 7:26 AM | marketbeat.com

Good Steward Wealth Advisors LLC Acquires New Holdings in Pfizer Inc. (NYSE:PFE)

June 20 at 6:33 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Sold by Means Investment CO. Inc.

June 20 at 5:48 AM | marketbeat.com

Pfizer: An Offensive Play For A Bear Market

June 20 at 5:20 AM | seekingalpha.com

Envestnet Portfolio Solutions Inc. Trims Stake in Pfizer Inc. (NYSE:PFE)

June 20 at 5:03 AM | marketbeat.com

Pfizer: An Offensive Play For A Bear Market

June 20 at 5:01 AM | seekingalpha.com

Pfizer Inc. (NYSE:PFE) Shares Bought by Johnson Investment Counsel Inc.

June 20 at 4:42 AM | marketbeat.com

Wealth Enhancement Advisory Services LLC Has $66.04 Million Holdings in Pfizer Inc. (NYSE:PFE)

June 20 at 3:47 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Stocks That Will Profit From a Golden Dome
By Chris Markoch | May 30, 2025
View 3 Defense Stocks That Will Profit From a Golden Dome
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
Analysts Think These Stocks Could More Than Double in Value
By Nathan Reiff | May 23, 2025
View Analysts Think These Stocks Could More Than Double in Value
Intel’s Turnaround May Be the Best Bet No One’s Watching
By Jeffrey Neal Johnson | May 30, 2025
View Intel’s Turnaround May Be the Best Bet No One’s Watching
Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings
By Thomas Hughes | May 27, 2025
View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings

KO, O, and PFE Company Descriptions

CocaCola NYSE:KO

$68.84 -0.37 (-0.53%)

Closing price 06/20/2025 03:59 PM Eastern

Extended Trading

$68.92 +0.08 (+0.11%)

As of 06/20/2025 07:59 PM Eastern

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Realty Income NYSE:O

$57.24 -0.34 (-0.59%)

Closing price 06/20/2025 03:59 PM Eastern

Extended Trading

$57.30 +0.06 (+0.10%)

As of 06/20/2025 07:56 PM Eastern

Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 15,450 real estate properties (including properties acquired in the Spirit merger in January 2024) primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 644 consecutive monthly dividends on its shares of common stock throughout its 55-year operating history and increased the dividend 123 times since Realty Income's public listing in 1994 (NYSE: O).

Pfizer NYSE:PFE

$23.97 +0.09 (+0.37%)

Closing price 06/20/2025 03:59 PM Eastern

Extended Trading

$23.99 +0.02 (+0.09%)

As of 06/20/2025 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time